Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arterial Pressure | 2 | 2014 | 47 | 0.930 |
Why?
|
| Monitoring, Physiologic | 2 | 2014 | 219 | 0.870 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 9 | 0.490 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2014 | 13 | 0.470 |
Why?
|
| Lactic Acid | 1 | 2014 | 86 | 0.460 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 258 | 0.450 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 296 | 0.430 |
Why?
|
| Spinal Cord | 1 | 2014 | 244 | 0.420 |
Why?
|
| Brain Injuries | 1 | 2014 | 268 | 0.380 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 551 | 0.290 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 10 | 0.180 |
Why?
|
| Thromboembolism | 1 | 2020 | 91 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2020 | 373 | 0.170 |
Why?
|
| Intracranial Aneurysm | 1 | 2020 | 87 | 0.160 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 150 | 0.150 |
Why?
|
| Hematoma, Subdural | 1 | 2014 | 19 | 0.120 |
Why?
|
| beta-Alanine | 1 | 2014 | 20 | 0.110 |
Why?
|
| Antithrombins | 1 | 2014 | 32 | 0.110 |
Why?
|
| Benzimidazoles | 1 | 2014 | 128 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2012 | 198 | 0.090 |
Why?
|
| Decision Making | 1 | 2014 | 410 | 0.090 |
Why?
|
| Myeloablative Agonists | 1 | 2006 | 4 | 0.070 |
Why?
|
| Busulfan | 1 | 2006 | 13 | 0.070 |
Why?
|
| Anemia, Aplastic | 1 | 2006 | 10 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 217 | 0.060 |
Why?
|
| Models, Animal | 1 | 2006 | 252 | 0.060 |
Why?
|
| Humans | 5 | 2020 | 68618 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2020 | 328 | 0.040 |
Why?
|
| Female | 3 | 2020 | 38074 | 0.040 |
Why?
|
| Male | 2 | 2020 | 37321 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.030 |
Why?
|
| Thrombelastography | 1 | 2014 | 19 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Dabigatran | 1 | 2014 | 35 | 0.030 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2012 | 5 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2012 | 45 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 98 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 225 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2012 | 356 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 498 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 7029 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 7277 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 772 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Splenic Neoplasms | 1 | 2006 | 5 | 0.020 |
Why?
|
| Thymus Neoplasms | 1 | 2006 | 17 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2006 | 35 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2006 | 97 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2006 | 144 | 0.020 |
Why?
|
| Lymphoma | 1 | 2006 | 116 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 301 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 532 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 4848 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 14862 | 0.010 |
Why?
|
| Hypertension | 1 | 2012 | 1535 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2324 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 21147 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 21403 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1641 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 8474 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 20881 | 0.000 |
Why?
|